16
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Intensive Sequential Therapy for VAD-Resistant Multiple Myeloma

, , , , &
Pages 479-484 | Received 17 Jul 1993, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Donna Weber, Meletios Dimopoulos, Frank Sinicrope & Raymond Alexanian. (1995) VAD-Cyclosporine Therapy for VAD-Resistant Multiple Myeloma. Leukemia & Lymphoma 19:1-2, pages 159-163.
Read now

Articles from other publishers (4)

Morie A. Gertz, Shaji Kumar, Martha Q. Lacy, Angela Dispenzieri, David Dingli, Suzanne R. Hayman, Francis K. Buadi & William J. Hogan. (2010) Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction. Blood 115:12, pages 2348-2353.
Crossref
Shirley D'Sa, Kwee Yong, Chara Kyriakou, Soumo Bhattacharya, Karl S. Peggs, Barbara Foulkes, Michael J. Watts, Stuart J. Ings, Kirit M. Ardeshna, Anthony H. Goldstone & Catherine D. Williams. (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. British Journal of Haematology 125:6, pages 756-765.
Crossref
Theresa Hahn, John R. Wingard, Kenneth C. Anderson, William I. Bensinger, James R. Berenson, Greg Brozeit, Joseph R. Carver, Robert A. Kyle & Philip L. McCarthyJrJr. (2003) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based review. Biology of Blood and Marrow Transplantation 9:1, pages 4-37.
Crossref
Agustin Avilés, Rosas T Alejandro, Judith Huerta-Guzmán, Alejandra Talavera & Sergio Cleto. (1999) Dexamethasone, All Trans Retinoic Acid and Interferon Alpha 2a in Patients with Refractory Multiple Myeloma. Cancer Biotherapy and Radiopharmaceuticals 14:1, pages 23-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.